| PERIOD ENDING | 27-Mar-09 | 2-Jan-09 | 5-Sep-08 | 13-Jun-08 | | Total Revenue | 2,495,000 | 3,784,000 | 2,963,000 | 3,185,000 | | Cost of Revenue | 2,237,000 | 3,385,000 | 2,593,000 | 2,688,000 | | | Gross Profit | 258,000 | 399,000 | 370,000 | 497,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 174,000 | 270,000 | 167,000 | 184,000 | | Non Recurring | 2,000 | 55,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 82,000 | 74,000 | 203,000 | 313,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11,000) | (18,000) | 41,000 | 18,000 | | Earnings Before Interest And Taxes | 37,000 | 71,000 | 220,000 | 328,000 | | Interest Expense | 29,000 | 50,000 | 33,000 | 38,000 | | Income Before Tax | 8,000 | 21,000 | 187,000 | 290,000 | | Income Tax Expense | 33,000 | 33,000 | 103,000 | 139,000 | | Minority Interest |
-
| 2,000 | 10,000 | 2,000 | | | | Net Income From Continuing Ops | (25,000) | (10,000) | 94,000 | 153,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 4,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (25,000) | (10,000) | 94,000 | 157,000 | | Preferred Stock And Other Adjustments | 2,000 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,000) | ($10,000) | $94,000 | $157,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
